Ancora Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Ancora Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $919 - $1,079	14 New	14 $1,000
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $14,248 - $22,734	150 New	150 $23,000
Q2 2021 Aug 13, 2021	SELL	$113.03 - $155.64 $16,954 - $23,345	-150 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $14,541 - $17,038	150 New	150 $16,000
Q4 2018 Feb 15, 2019	SELL	$128.36 - $272.13 $19,254 - $40,819	-150 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $31,677 - $41,173	150 New	150 $41,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.1B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.